SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001193125-20-143985
Filing Date
2020-05-15
Accepted
2020-05-15 16:15:18
Documents
9
Effectiveness Date
2020-05-15

Document Format Files

Seq Description Document Type Size
1 S-3ASR d923912ds3asr.htm S-3ASR 323558
2 EX-4.6 d923912dex46.htm EX-4.6 321705
3 EX-4.9 d923912dex49.htm EX-4.9 100858
4 EX-4.10 d923912dex410.htm EX-4.10 105311
5 EX-4.11 d923912dex411.htm EX-4.11 91619
6 EX-5.1 d923912dex51.htm EX-5.1 26458
7 EX-23.1 d923912dex231.htm EX-23.1 1825
8 GRAPHIC g923912g04n66.jpg GRAPHIC 56737
9 GRAPHIC g923912g0512084258000.jpg GRAPHIC 2534
  Complete submission text file 0001193125-20-143985.txt   1054506
Mailing Address 10628 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121 858-926-5251
Turning Point Therapeutics, Inc. (Filer) CIK: 0001595893 (see all company filings)

IRS No.: 463826166 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-238300 | Film No.: 20885388
SIC: 2834 Pharmaceutical Preparations